No CrossRef data available.
Article contents
Distribution of Central Line-Associated Bloodstream Infections Determined From Washington State’s Annual Reporting Validation Program, 2009–2013
Published online by Cambridge University Press: 28 December 2016
Abstract
Healthcare-associated infection reporting validation is essential because this information is increasingly used in public healthcare quality assurances and care reimbursement. Washington State’s validation of central line-associated bloodstream infection reporting applies credible quality sciences methods to ensure that hospital reporting accuracy is maintained. This paper details findings and costs from our experience.
Infect Control Hosp Epidemiol 2017;38:489–492
- Type
- Concise Communications
- Information
- Copyright
- © 2016 by The Society for Healthcare Epidemiology of America. All rights reserved
Footnotes
PREVIOUS PRESENTATIONS: These findings were previously reported by J.M.L., M.J.C., and D.W.B. as a poster titled “Distribution of Central Line-Associated Bloodstream Infections Determined from Washington State’s Annual Reporting Validation Program, 2009–2013” at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference in Nashville, Tennessee, on June 23, 2014, and by J.M.L., M.J.C., D.W.B., and P.G. Lovinger as a poster titled “Cost of a Sustainable Annual Validation Process to Ensure Credibility of State HAI Reporting” at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference in Nashville, Tennessee, on June 23, 2014.